Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of October 2025. The report specifically addresses the company's total voting rights and capital structure as of September 30, 2025. Haleon operates across six major categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on share capital and voting rights data.
Material Changes and Capital Structure
- Total Issued Shares: 8,952,353,648 ordinary shares of £0.01 each.
- Treasury Shares: 44,400,783 shares held as treasury stock.
- Voting Shares: 8,907,952,865 ordinary shares with voting rights.
The number of voting shares serves as the denominator for shareholders to calculate notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on performance, specific risks, contingencies, or unusual items. The document is a statutory notification of share capital.
Key Facts for Investor Verification
- Verify the denominator for disclosure calculations is 8,907,952,865 voting shares.
- Confirm the date of the capital data is September 30, 2025.
- Note that this filing contains no financial performance data for the period.
- Contact the Company Secretary at company.secretary@haleon.com for notifiable interest submissions.